Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1984 1
1985 1
1987 2
1988 4
1989 3
1990 4
1991 3
1992 1
1993 2
1994 3
1995 3
1996 5
1997 3
1998 7
1999 4
2000 12
2001 6
2002 10
2003 8
2004 5
2005 9
2006 3
2007 9
2008 10
2009 9
2010 9
2011 6
2012 5
2013 9
2014 3
2015 2
2016 2
2017 4
2018 9
2019 10
2020 7
2021 6
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

201 results
Results by year
Filters applied: . Clear all
Page 1
Long-Acting HIV Drugs for Treatment and Prevention.
Gulick RM, Flexner C. Gulick RM, et al. Among authors: flexner c. Annu Rev Med. 2019 Jan 27;70:137-150. doi: 10.1146/annurev-med-041217-013717. Epub 2018 Oct 24. Annu Rev Med. 2019. PMID: 30355266 Review.
Tipranavir.
Flexner C, Bate G, Kirkpatrick P. Flexner C, et al. Nat Rev Drug Discov. 2005 Dec;4(12):955-6. doi: 10.1038/nrd1907. Nat Rev Drug Discov. 2005. PMID: 16370086 No abstract available.
HIV-protease inhibitors.
Flexner C. Flexner C. N Engl J Med. 1998 Apr 30;338(18):1281-92. doi: 10.1056/NEJM199804303381808. N Engl J Med. 1998. PMID: 9562584 Review. No abstract available.
Why a universal antiretroviral regimen?
Flexner CW, Clayden P, Venter WDF. Flexner CW, et al. Curr Opin HIV AIDS. 2017 Jul;12(4):315-317. doi: 10.1097/COH.0000000000000390. Curr Opin HIV AIDS. 2017. PMID: 28486340 Free PMC article. No abstract available.
Impact of long-acting therapies on the global HIV epidemic.
Chandiwana NC, Serenata CM, Owen A, Rannard S, Pérez Casas C, Scott C, Hill A, Clayden P, Flexner C. Chandiwana NC, et al. Among authors: flexner c. AIDS. 2021 Dec 15;35(Suppl 2):S137-S143. doi: 10.1097/QAD.0000000000003102. AIDS. 2021. PMID: 34848580
201 results